vida: extract claims from 2025-09-22-gao-physician-consolidation-price-quality

- Source: inbox/queue/2025-09-22-gao-physician-consolidation-price-quality.md
- Domain: health
- Claims: 2, Entities: 0
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md

@@ -1,23 +1,13 @@
 ---
-description: Drug overdoses alcohol abuse and suicide -- deaths of despair -- reversed US life expectancy after 2014 with geographic and demographic patterns matching deindustrialization and widening inequality not random distribution
 type: claim
 domain: health
-source: "Architectural Investing, Ch. Epidemiological Transition; JAMA 2019"
+description: Drug overdoses alcohol abuse and suicide -- deaths of despair -- reversed US life expectancy after 2014 with geographic and demographic patterns matching deindustrialization and widening inequality not random distribution
 confidence: proven
+source: Architectural Investing, Ch. Epidemiological Transition; JAMA 2019
 created: 2026-02-28
-related_claims:
-  - cvd-mortality-stagnation-affects-all-income-levels-indicating-structural-system-failure
-  - us-cardiovascular-mortality-gains-reversing-after-decades-of-improvement-across-major-conditions
-  - cvd-stagnation-drives-us-life-expectancy-plateau-3-11x-more-than-drug-deaths
-  - us-healthspan-declining-while-lifespan-recovers-creating-divergence
-  - us-healthspan-lifespan-gap-largest-globally-despite-highest-spending
-  - us-hypertension-mortality-doubled-2000-2019-while-treatment-control-stagnated-structural-access-failure
-related:
-- hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure
-- after a threshold of material development relative deprivation replaces absolute deprivation as the primary driver of health outcomes
-reweave_edges:
-- hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure|related|2026-03-31
-- after a threshold of material development relative deprivation replaces absolute deprivation as the primary driver of health outcomes|related|2026-04-17
+related_claims: ["cvd-mortality-stagnation-affects-all-income-levels-indicating-structural-system-failure", "us-cardiovascular-mortality-gains-reversing-after-decades-of-improvement-across-major-conditions", "cvd-stagnation-drives-us-life-expectancy-plateau-3-11x-more-than-drug-deaths", "us-healthspan-declining-while-lifespan-recovers-creating-divergence", "us-healthspan-lifespan-gap-largest-globally-despite-highest-spending", "us-hypertension-mortality-doubled-2000-2019-while-treatment-control-stagnated-structural-access-failure"]
+related: ["hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure", "after a threshold of material development relative deprivation replaces absolute deprivation as the primary driver of health outcomes", "Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s"]
+reweave_edges: ["hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure|related|2026-03-31", "after a threshold of material development relative deprivation replaces absolute deprivation as the primary driver of health outcomes|related|2026-04-17"]
 ---
 
 # Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s
@@ -69,4 +59,10 @@ Relevant Notes:
 
 Topics:
 - health and wellness
-- livingip overview
+- livingip overview
+
+## Supporting Evidence
+
+**Source:** Papanicolas et al., JAMA Internal Medicine 2025
+
+Drug-related deaths contributed 71.1% of the increase in preventable avoidable deaths from external causes during 2009-2019, providing precise quantification of the deaths-of-despair mechanism's contribution to US mortality divergence. The study shows this operated across all 50 states with West Virginia experiencing the worst increase (+99.6 per 100,000) while even the best-performing state (New York, -4.9) could not escape the broader deterioration pattern.

domains/health/glp1-long-term-persistence-ceiling-14-percent-year-two.md

@@ -23,3 +23,10 @@ Despite the near-doubling of year-one persistence rates, Prime Therapeutics data
 **Source:** KFF 2025 poll
 
 Cost is a major driver of discontinuation: 14% of former GLP-1 users stopped due to cost, matching the 13% who stopped due to side effects. Among current users, 56% report difficulty affording medications, suggesting cost pressure operates throughout the treatment duration, not just at initiation. The 27% of insured users paying full out-of-pocket cost indicates insurance coverage gaps contribute to persistence failures.
+
+
+## Extending Evidence
+
+**Source:** Cell/Med 2025, The Societal Implications of Using GLP-1 Receptor Agonists for the Treatment of Obesity
+
+Cell/Med 2025 connects low persistence rates to the sustainability concern: chronic use model + high prices + discontinuation effects = fiscal unsustainability at scale. The paper notes need to 'consider acceptability over long term and implications for weight stigma,' suggesting that persistence barriers are not just clinical or financial but also social. The equity inversion compounds this: those with highest need face both highest discontinuation rates (per existing KB claims on wealth-stratified access) and lowest initial access, creating a double barrier to population-level impact.

domains/health/medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md

@@ -1,26 +1,14 @@
 ---
-description: Schroeder 2007 attributes 10 percent of premature deaths to healthcare while Braveman-Egerter 2019 reviews four methods converging on the same estimate -- the 90 percent non-clinical claim is directionally correct but rhetorically imprecise
 type: claim
 domain: health
-created: 2026-02-20
-source: "Braveman & Egerter 2019, Schroeder 2007, County Health Rankings, Dever 1976"
+description: Schroeder 2007 attributes 10 percent of premature deaths to healthcare while Braveman-Egerter 2019 reviews four methods converging on the same estimate -- the 90 percent non-clinical claim is directionally correct but rhetorically imprecise
 confidence: proven
-related_claims:
-  - snap-benefit-loss-causes-measurable-mortality-through-food-insecurity-pathway
-  - snap-reduces-antihypertensive-nonadherence-through-food-medication-trade-off-relief
-  - us-healthspan-lifespan-gap-largest-globally-despite-highest-spending
-  - us-healthspan-declining-while-lifespan-recovers-creating-divergence
-  - cvd-mortality-stagnation-affects-all-income-levels-indicating-structural-system-failure
-  - us-hypertension-mortality-doubled-2000-2019-while-treatment-control-stagnated-structural-access-failure
-supports:
-- hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure
-- The US healthcare spending/outcome paradox — world-class acute care outcomes with dramatically worse preventable mortality — is the strongest empirical confirmation that non-clinical factors dominate population health
-reweave_edges:
-- hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure|supports|2026-03-31
-- us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality|related|2026-04-04
-- The US healthcare spending/outcome paradox — world-class acute care outcomes with dramatically worse preventable mortality — is the strongest empirical confirmation that non-clinical factors dominate population health|supports|2026-04-24
-related:
-- us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality
+source: "Braveman & Egerter 2019, Schroeder 2007, County Health Rankings, Dever 1976"
+created: 2026-02-20
+related_claims: ["snap-benefit-loss-causes-measurable-mortality-through-food-insecurity-pathway", "snap-reduces-antihypertensive-nonadherence-through-food-medication-trade-off-relief", "us-healthspan-lifespan-gap-largest-globally-despite-highest-spending", "us-healthspan-declining-while-lifespan-recovers-creating-divergence", "cvd-mortality-stagnation-affects-all-income-levels-indicating-structural-system-failure", "us-hypertension-mortality-doubled-2000-2019-while-treatment-control-stagnated-structural-access-failure"]
+supports: ["hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure", "The US healthcare spending/outcome paradox \u2014 world-class acute care outcomes with dramatically worse preventable mortality \u2014 is the strongest empirical confirmation that non-clinical factors dominate population health"]
+reweave_edges: ["hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure|supports|2026-03-31", "us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality|related|2026-04-04", "The US healthcare spending/outcome paradox \u2014 world-class acute care outcomes with dramatically worse preventable mortality \u2014 is the strongest empirical confirmation that non-clinical factors dominate population health|supports|2026-04-24"]
+related: ["us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality", "medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm"]
 ---
 
 # medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm
@@ -104,4 +92,10 @@ Relevant Notes:
 - [[human needs are finite universal and stable across millennia making them the invariant constraints from which industry attractor states can be derived]] -- health needs are a subset of universal needs, and the attractor state must address the full spectrum not just clinical encounters
 
 Topics:
-- health and wellness
+- health and wellness
+
+## Supporting Evidence
+
+**Source:** Papanicolas et al., JAMA Internal Medicine 2025
+
+The 3:1 ratio of preventable (24.3 per 100,000) to treatable (7.5 per 100,000) mortality increase from 2009-2019 provides direct empirical evidence that behavioral and social determinants dominate over clinical care factors in US health outcomes. The spending-mortality correlation breakdown (-0.12 in US states vs -0.7 in peer nations) demonstrates that clinical spending cannot address the primary drivers of US mortality deterioration.

domains/health/physician-consolidation-raises-commercial-prices-16-21-percent-without-quality-improvement.md

@@ -0,0 +1,19 @@
+---
+type: claim
+domain: health
+description: GAO systematic review finds strong evidence for price increases but mixed evidence on quality, confirming consolidation extracts rent without health value
+confidence: likely
+source: US Government Accountability Office GAO-25-107450, September 2025
+created: 2026-04-26
+title: "Physician consolidation with hospital systems raises commercial insurance prices 16-21% for specialty procedures while producing no consistent quality improvement"
+agent: vida
+sourced_from: health/2025-09-22-gao-physician-consolidation-price-quality.md
+scope: causal
+sourcer: US Government Accountability Office
+supports: ["four-competing-payer-provider-models-are-converging-toward-value-based-care-with-vertical-integration-dominant-today-but-aligned-partnership-potentially-more-durable", "value-based-care-transitions-stall-at-the-payment-boundary-because-60-percent-of-payments-touch-value-metrics-but-only-14-percent-bear-full-risk"]
+related: ["four-competing-payer-provider-models-are-converging-toward-value-based-care-with-vertical-integration-dominant-today-but-aligned-partnership-potentially-more-durable", "value-based-care-transitions-stall-at-the-payment-boundary-because-60-percent-of-payments-touch-value-metrics-but-only-14-percent-bear-full-risk", "hospital-physician-consolidation-increases-prices-without-improving-quality"]
+---
+
+# Physician consolidation with hospital systems raises commercial insurance prices 16-21% for specialty procedures while producing no consistent quality improvement
+
+The GAO's systematic review of published literature found that hospital-affiliated specialists negotiated 16.3% higher prices for cardiology procedures and 20.7% higher prices for gastroenterology compared to independent practices in commercial insurance markets. Private equity-affiliated specialists charged 6.0% higher for cardiology and 10.0% higher for gastroenterology. The GAO estimated that if hospital and PE specialists charged equivalent to independent practices, commercial spending would be approximately $3.05 billion lower per year ($2.9B from hospital consolidation, $156M from PE). Critically, studies on quality effects were 'split between findings of no change or a decline in quality' — one colonoscopy study found patients more likely to experience complications after gastroenterologists consolidated with hospitals. The GAO 'was unable to find any studies' meeting its standards on consolidation's effect on care access. This confirms that consolidation creates measurable price premiums without corresponding quality improvements, fitting the definition of rent extraction. The mechanism is structural: consolidated practices gain negotiating leverage with commercial payers while hospital employment enables billing at higher facility rates, but these financial advantages don't translate to better clinical outcomes.

domains/health/private-equity-drives-65-percent-physician-acquisitions-while-owning-7-percent-practices.md

@@ -0,0 +1,18 @@
+---
+type: claim
+domain: health
+description: PE acquisition velocity far exceeds current ownership, signaling the physician employment transformation is in early acceleration phase
+confidence: experimental
+source: US Government Accountability Office GAO-25-107450, September 2025
+created: 2026-04-26
+title: "Private equity firms drove 65% of physician practice acquisitions from 2019-2023 while owning only 7% of practices, indicating structural transformation is accelerating faster than ownership share suggests"
+agent: vida
+sourced_from: health/2025-09-22-gao-physician-consolidation-price-quality.md
+scope: structural
+sourcer: US Government Accountability Office
+related: ["physician-consolidation-raises-commercial-prices-16-21-percent-without-quality-improvement"]
+---
+
+# Private equity firms drove 65% of physician practice acquisitions from 2019-2023 while owning only 7% of practices, indicating structural transformation is accelerating faster than ownership share suggests
+
+The GAO report documents that private equity firms were responsible for 65% of all physician practice acquisitions from 2019-2023, yet PE ownership represents only 6.5-7% of physicians nationally as of 2024 (up from ~5% in 2022). This creates a striking velocity-to-ownership ratio: PE is acquiring practices at a rate 9-10x faster than its current market share would suggest. The mechanism is consolidation acceleration — PE firms are actively transforming the physician employment landscape through rapid acquisition, but the ownership percentage lags because the transformation is still in early stages. This matters because it indicates the structural shift from independent to employed physicians (which fell from 60% independent in 2012 to 42% in 2024) is not slowing but accelerating. The PE acquisition rate is the leading indicator; the ownership percentage is the lagging indicator. If PE maintains this acquisition velocity, the 7% ownership share could double within 3-4 years, fundamentally altering the physician employment structure and the associated price effects documented in the GAO report.

domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md

@@ -1,13 +1,12 @@
 ---
-description: Derived using the 8-component template -- three core interrelated layers (VBC payment alignment, AI-enabled proactive care, continuous biometric monitoring) plus contested dimensions around social determinants and administrative simplification, classified as a weak attractor with multiple locally stable configurations
 type: claim
 domain: health
-created: 2026-03-01
-source: "Healthcare attractor state derivation using vault knowledge + 2026 industry research; Rumelt Good Strategy Bad Strategy; Devoted Health analysis; CMS data; OECD comparisons; Singapore model"
+description: Derived using the 8-component template -- three core interrelated layers (VBC payment alignment, AI-enabled proactive care, continuous biometric monitoring) plus contested dimensions around social determinants and administrative simplification, classified as a weak attractor with multiple locally stable configurations
 confidence: likely
-related_claims:
-  - divergence-prevention-first-cost-reduction-vs-cost-redistribution
-  - medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-supplement-to-dominant-program
+source: Healthcare attractor state derivation using vault knowledge + 2026 industry research; Rumelt Good Strategy Bad Strategy; Devoted Health analysis; CMS data; OECD comparisons; Singapore model
+created: 2026-03-01
+related_claims: ["divergence-prevention-first-cost-reduction-vs-cost-redistribution", "medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-supplement-to-dominant-program"]
+related: ["the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness", "us-healthcare-spending-outcome-paradox-confirms-non-clinical-factors-dominate-population-health", "us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality", "home-based-care-could-capture-265-billion-in-medicare-spending-by-2025-through-hospital-at-home-remote-monitoring-and-post-acute-shift", "medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm"]
 ---
 
 # the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness
@@ -357,3 +356,10 @@ Topics:
 - health and wellness
 - attractor dynamics
 - livingip overview
+
+
+## Supporting Evidence
+
+**Source:** Papanicolas et al., JAMA Internal Medicine 2025, OECD Health at a Glance 2025
+
+Current US system shows treatable mortality gap of 95 vs OECD average 77 per 100,000 (confirming clinical system underperformance) and preventable mortality gap of 217 vs OECD average 145 (confirming the behavioral/social failure is larger). The spending-outcome decoupling within US states proves the current sick-care architecture cannot bend the curve even with higher spending, validating the need for structural transition to prevention-first systems.

domains/health/us-avoidable-mortality-increased-all-states-while-oecd-declined-with-health-spending-structurally-decoupled-from-outcomes.md

@@ -0,0 +1,23 @@
+---
+type: claim
+domain: health
+description: The correlation between health spending and avoidable mortality is -0.7 in comparator countries but -0.12 (non-significant) across US states, indicating the US healthcare architecture cannot address its primary health burden through additional clinical spending
+confidence: proven
+source: Papanicolas et al., JAMA Internal Medicine 2025
+created: 2026-04-26
+title: US avoidable mortality increased in all 50 states from 2009-2019 while declining in most high-income countries, with health spending structurally decoupled from outcomes within the US but not in peer nations
+agent: vida
+sourced_from: health/2025-03-24-papanicolas-jama-avoidable-mortality-us-oecd.md
+scope: structural
+sourcer: Irene Papanicolas, Ashish K. Jha, et al.
+supports: ["Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s", "medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm", "us-healthcare-spending-outcome-paradox-confirms-non-clinical-factors-dominate-population-health"]
+related: ["Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s", "medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm", "us-healthcare-spending-outcome-paradox-confirms-non-clinical-factors-dominate-population-health", "us-healthspan-lifespan-gap-largest-globally-despite-highest-spending", "us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality"]
+---
+
+# US avoidable mortality increased in all 50 states from 2009-2019 while declining in most high-income countries, with health spending structurally decoupled from outcomes within the US but not in peer nations
+
+This study provides definitive evidence of a structural divergence in health system performance. From 2009-2019, avoidable mortality increased by a median 29.0 per 100,000 across US states (total average increase 32.5), while EU countries decreased by 25.2 and OECD countries by 22.8. The directional divergence is total: ALL US states worsened while most comparator countries improved. The state-level range widened dramatically from 251.1-280.4 in 2009 to 282.8-329.5 in 2019, with West Virginia worst at +99.6 increase and New York slightly improved at -4.9.
+
+The critical finding is the spending-mortality relationship breakdown. In comparator countries, health spending shows a strong negative correlation with avoidable mortality (r = -0.7), meaning more spending associates with better outcomes. Across US states, this correlation is -0.12 and statistically non-significant. The authors state: 'While other countries appear to make gains in health with increases in health care spending, such an association does not exist across US states.' This is not a marginal difference but a structural dissociation—US healthcare spending literally does not move the avoidable mortality needle at the state level, while it does in every comparable country.
+
+The increase was driven primarily by preventable mortality (24.3 per 100,000) versus treatable mortality (7.5 per 100,000)—a 3:1 ratio indicating that public health and prevention failures dominate over clinical care failures. External causes dominated, with drug-related deaths contributing 71.1% of the increase in preventable avoidable deaths from external causes. This confirms that the US health crisis operates through behavioral and social determinant pathways that the current clinical care architecture cannot address, even with higher spending.

inbox/archive/health/2025-03-24-papanicolas-jama-avoidable-mortality-us-oecd.md

@@ -7,9 +7,12 @@ date: 2025-03-24
 domain: health
 secondary_domains: []
 format: peer-reviewed study
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-26
 priority: high
 tags: [avoidable-mortality, preventable-mortality, treatable-mortality, OECD, US-health-outcomes, health-spending-efficiency, deaths-of-despair, drug-overdose]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content

inbox/archive/health/2025-07-01-cell-med-glp1-societal-implications-equity.md

@@ -7,9 +7,12 @@ date: 2025-07-01
 domain: health
 secondary_domains: []
 format: commentary-analysis
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-26
 priority: high
 tags: [glp-1, obesity, equity, health-disparities, access, social-determinants, prevention, societal-implications]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content

inbox/archive/health/2025-09-22-gao-physician-consolidation-price-quality.md

@@ -7,9 +7,12 @@ date: 2025-09-22
 domain: health
 secondary_domains: []
 format: government-report
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-26
 priority: high
 tags: [consolidation, physician-consolidation, private-equity, hospital-employment, price-effects, quality-effects, healthcare-markets]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content